121 related articles for article (PubMed ID: 38549356)
1. Effect of the human papillomavirus vaccine on the risk of genital warts: a nationwide cohort study of South Korean adolescent girls.
Cho J; Kim EM; Kim J; Shin JY; Kim EH; Park JH; Kwon SL; Kwon GY; Shin SA; Kim J
Epidemiol Health; 2024 Mar; ():e2024040. PubMed ID: 38549356
[TBL] [Abstract][Full Text] [Related]
2. Strongly decreased risk of genital warts after vaccination against human papillomavirus: nationwide follow-up of vaccinated and unvaccinated girls in Denmark.
Blomberg M; Dehlendorff C; Munk C; Kjaer SK
Clin Infect Dis; 2013 Oct; 57(7):929-34. PubMed ID: 23804192
[TBL] [Abstract][Full Text] [Related]
3. One-Dose Human Papillomavirus Vaccination and the Risk of Genital Warts: A Danish Nationwide Population-based Study.
Baandrup L; Dehlendorff C; Kjaer SK
Clin Infect Dis; 2021 Nov; 73(9):e3220-e3226. PubMed ID: 33048118
[TBL] [Abstract][Full Text] [Related]
4. Association between human papillomavirus vaccination and serious adverse events in South Korean adolescent girls: nationwide cohort study.
Yoon D; Lee JH; Lee H; Shin JY
BMJ; 2021 Jan; 372():m4931. PubMed ID: 33514507
[TBL] [Abstract][Full Text] [Related]
5. Evaluating the Early Benefit of Quadrivalent HPV Vaccine on Genital Warts in Belgium: A Cohort Study.
Dominiak-Felden G; Gobbo C; Simondon F
PLoS One; 2015; 10(7):e0132404. PubMed ID: 26147096
[TBL] [Abstract][Full Text] [Related]
6. The impact of HPV multi-cohort vaccination: Real-world evidence of faster control of HPV-related morbidity.
Orumaa M; Kjaer SK; Dehlendorff C; Munk C; Olsen AO; Hansen BT; Campbell S; Nygård M
Vaccine; 2020 Feb; 38(6):1345-1351. PubMed ID: 31917039
[TBL] [Abstract][Full Text] [Related]
7. Dose-Related Differences in Effectiveness of Human Papillomavirus Vaccination Against Genital Warts: A Nationwide Study of 550,000 Young Girls.
Blomberg M; Dehlendorff C; Sand C; Kjaer SK
Clin Infect Dis; 2015 Sep; 61(5):676-82. PubMed ID: 25944340
[TBL] [Abstract][Full Text] [Related]
8. Significant decrease in the incidence of genital warts in young Danish women after implementation of a national human papillomavirus vaccination program.
Baandrup L; Blomberg M; Dehlendorff C; Sand C; Andersen KK; Kjaer SK
Sex Transm Dis; 2013 Feb; 40(2):130-5. PubMed ID: 23324976
[TBL] [Abstract][Full Text] [Related]
9. Epidemiological impact of the human papillomavirus vaccination program on genital warts in Portugal: A retrospective, chart review study.
Fernandes C; Alves J; Rodrigues A; Azevedo J;
Vaccine; 2022 Jan; 40(2):275-281. PubMed ID: 34953608
[TBL] [Abstract][Full Text] [Related]
10. Impact of a population-based HPV vaccination program on cervical abnormalities: a data linkage study.
Gertig DM; Brotherton JM; Budd AC; Drennan K; Chappell G; Saville AM
BMC Med; 2013 Oct; 11():227. PubMed ID: 24148310
[TBL] [Abstract][Full Text] [Related]
11. HPV vaccination leads to decrease of anogenital warts and precancerous lesions of the cervix uteri in young women with low vaccination rates: a retrospective cohort analysis.
Osmani V; Fett S; Tauscher M; Donnachie E; Schneider A; Klug SJ
BMC Cancer; 2022 Dec; 22(1):1293. PubMed ID: 36494790
[TBL] [Abstract][Full Text] [Related]
12. Effectiveness of HPV vaccines against genital warts in women from Valencia, Spain.
Navarro-Illana E; López-Lacort M; Navarro-Illana P; Vilata JJ; Diez-Domingo J
Vaccine; 2017 Jun; 35(25):3342-3346. PubMed ID: 28499554
[TBL] [Abstract][Full Text] [Related]
13. Human papillomavirus vaccines effectiveness to prevent genital warts: A population-based study using health system integrated databases, 2009-2017.
Muñoz-Quiles C; López-Lacort M; Díez-Domingo J; Rodrigo-Casares V; Orrico-Sánchez A
Vaccine; 2022 Jan; 40(2):316-324. PubMed ID: 34865874
[TBL] [Abstract][Full Text] [Related]
14. Quadrivalent human papillomavirus vaccine effectiveness: a Swedish national cohort study.
Leval A; Herweijer E; Ploner A; Eloranta S; Fridman Simard J; Dillner J; Young C; Netterlid E; Sparén P; Arnheim-Dahlström L
J Natl Cancer Inst; 2013 Apr; 105(7):469-74. PubMed ID: 23486550
[TBL] [Abstract][Full Text] [Related]
15. Substantial Decline in Prevalence of Vaccine-Type and Nonvaccine-Type Human Papillomavirus (HPV) in Vaccinated and Unvaccinated Girls 5 Years After Implementing HPV Vaccine in Norway.
Feiring B; Laake I; Christiansen IK; Hansen M; Stålcrantz J; Ambur OH; Magnus P; Jonassen CM; Trogstad L
J Infect Dis; 2018 Nov; 218(12):1900-1910. PubMed ID: 30010913
[TBL] [Abstract][Full Text] [Related]
16. Genital Warts in Women Vaccinated against HPV in Childhood: A Systematic Review.
Malheiro R; Magalhães C; Dias CC; Rodrigues AG; Lisboa C
Vaccines (Basel); 2024 May; 12(5):. PubMed ID: 38793799
[TBL] [Abstract][Full Text] [Related]
17. Quadrivalent HPV vaccine effectiveness against anogenital warts: A registry-based study of 2,2 million individuals.
Nygård S; Nygård M; Orumaa M; Hansen BT
Vaccine; 2023 Aug; 41(37):5469-5476. PubMed ID: 37516572
[TBL] [Abstract][Full Text] [Related]
18. An observational study comparing HPV prevalence and type distribution between HPV-vaccinated and -unvaccinated girls after introduction of school-based HPV vaccination in Norway.
Enerly E; Flingtorp R; Christiansen IK; Campbell S; Hansen M; Myklebust TÅ; Weiderpass E; Nygård M
PLoS One; 2019; 14(10):e0223612. PubMed ID: 31600341
[TBL] [Abstract][Full Text] [Related]
19. Significant Reduction in the Incidence of Genital Warts in Young Men 5 Years into the Danish Human Papillomavirus Vaccination Program for Girls and Women.
Bollerup S; Baldur-Felskov B; Blomberg M; Baandrup L; Dehlendorff C; Kjaer SK
Sex Transm Dis; 2016 Apr; 43(4):238-42. PubMed ID: 26967300
[TBL] [Abstract][Full Text] [Related]
20. The Longitudinal Incidence of Human Papillomavirus Vaccination in Spanish Primary Care in the First 10 Years After Approval.
Martín-Merino E; Llorente-García A; Castillo Cano B; Montero Corominas D; Huerta-Álvarez C
Pharmaceut Med; 2019 Dec; 33(6):519-530. PubMed ID: 31933243
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
